BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8019717)

  • 41. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. When bile ducts say NO: the good, the bad, and the ugly.
    Trauner M
    Gastroenterology; 2003 Mar; 124(3):847-51. PubMed ID: 12612920
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cholangiocarcinoma among printing workers].
    Kumagai S
    Nihon Rinsho; 2014 Feb; 72(2):306-9. PubMed ID: 24605532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct.
    Lee KT; Sheen PC
    J Surg Oncol; 1995 Jun; 59(2):131-5. PubMed ID: 7776654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholangiocarcinoma as related to chronic intrahepatic cholangitis and hepatolithiasis. Case report and review of the literature.
    Falchuk KR; Lesser PB; Galdabini JJ; Isselbacher KJ
    Am J Gastroenterol; 1976 Jul; 66(1):57-61. PubMed ID: 184709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignancy associated with hepatolithiasis.
    Chu KM; Lo CM; Liu CL; Fan ST
    Hepatogastroenterology; 1997; 44(14):352-7. PubMed ID: 9164501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer genes and cholangiocarcinoma.
    Petmitr S
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():80-4. PubMed ID: 9656355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parapapillary choledochoduodenal fistula associated with cholangiocarcinoma.
    Kuroki T; Fukuda K; Tajima Y; Matsuzaki S; Kitajima T; Furui J; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2005; 12(2):143-6. PubMed ID: 15868079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of tenascin in bile duct cancer of hamster liver by combined treatment of dimethylnitrosamine with Opisthorchis viverrini infections.
    Sithithaworn P; Ando K; Limviroj W; Tesana S; Pairojkul C; Yutanawiboonchai W; Chinzei Y; Yoshida T; Sakakura T
    J Helminthol; 2002 Sep; 76(3):261-8. PubMed ID: 12363380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral cholangiocarcinoma with thoracic spine metastasis: a successful surgically treated case.
    Yeh CN; Chen MF; Chen TC; Tseng JH
    Int Surg; 2001; 86(4):225-8. PubMed ID: 12056466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highlights of topic "Etiology and epidemiology of cholangiocarcinoma".
    Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):299-300. PubMed ID: 24740851
    [No Abstract]   [Full Text] [Related]  

  • 53. [Cholangiocarcinoma in genetic hemochromatosis].
    Margerit D; Kraimps JL; Kharitonoff T; Barbier J
    Presse Med; 1996 Apr; 25(15):732. PubMed ID: 8685142
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years.
    Suzuki Y; Mori T; Yokoyama M; Nakazato T; Abe N; Nakanuma Y; Tsubouchi H; Sugiyama M
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):617-22. PubMed ID: 24824191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peroral cholangioscopic treatment of hepatolithiasis: Long-term results.
    Okugawa T; Tsuyuguchi T; K C S; Ando T; Ishihara T; Yamaguchi T; Yugi H; Saisho H
    Gastrointest Endosc; 2002 Sep; 56(3):366-71. PubMed ID: 12196774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intrahepatic cholangiocarcinoma associated with viral hepatitis].
    Uenishi T; Yamamoto T; Takemura S; Sakata C; Kubo S
    Nihon Shokakibyo Gakkai Zasshi; 2012 Nov; 109(11):1872-7. PubMed ID: 23132030
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cholangiocarcinoma among printing workers].
    Kumagai S
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():827-31. PubMed ID: 25857144
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study.
    Liu ZY; Zhou YM; Shi LH; Yin ZF
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):626-31. PubMed ID: 22146627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatolithiasis associated with cholangiocarcinoma.
    Kubo S; Kinoshita H; Hirohashi K; Hamba H
    World J Surg; 1995; 19(4):637-41. PubMed ID: 7676713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.